NCT04136470 2020-08-10BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and DiagnosticsArdigenUnknown130 enrolled
NCT02543645 2018-04-30A Study of Varlilumab and Atezolizumab in Patients With Advanced CancerCelldex TherapeuticsPhase 1 Terminated18 enrolled